Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues, and monitoring the safety of pregnancy interventions

While vaccines are rigorously tested for safety and efficacy in clinical trials, these trials do not include enough subjects to detect rare adverse events, and they generally exclude special populations such as pregnant women. It is therefore necessary to conduct postmarketing vaccine safety assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodd, Caitlin, Andrews, Nick, Petousis-Harris, Helen, Sturkenboom, Miriam, Omer, Saad B, Black, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137251/
https://www.ncbi.nlm.nih.gov/pubmed/34011501
http://dx.doi.org/10.1136/bmjgh-2020-003540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137251/
https://www.ncbi.nlm.nih.gov/pubmed/34011501
http://dx.doi.org/10.1136/bmjgh-2020-003540

Ejemplares similares